The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction–associated steatotic hepatitis (MASH) is a chronic progressive liver disease that is highly prevalent worldwide. MASH is characterized by hepatic steatosis, inflammation, fibrosis, and liver damage, which eventually result in liver dysfunction due to cirrhosis or hepatocellular carcinoma. However, the cellular and molecular mechanisms underlying MASH progression remain largely unknown. Here, we found an increase of the Nr4a family of orphan nuclear receptor expression in intrahepatic T cells from mice with diet-induced MASH. Loss of Nr4a1 and Nr4a2 in T cell (dKO) ameliorated liver cell death and fibrosis, thereby mitigating liver dysfunction in MASH mice. dKO resulted in reduction of infiltrated macrophages and Th1/Th17 cells, whereas it led to a massive accumulation of Tregs in the liver of MASH mice. Combined single-cell RNA transcriptomic and TCR sequencing analysis revealed that intrahepatic dKO Tregs exhibited enhanced T cell immunoreceptor with Ig and ITIM domains (TIGIT) and IL-10 expression and were clonally expanded during MASH progression. Mechanistically, we found that dKO Tregs expressed high levels of basic leucine zipper ATF-like transcription factor (Batf), which promotes Treg cell proliferation and function upon TCR stimulation. Collectively, our findings not only provide an insight into the impact of intrahepatic Treg cells on MASH pathogenesis, but also suggest a therapeutic potential of targeting of the Nr4a family to treat the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, the role of hepatic Tregs in MASH has been explored only sparingly, and the limited studies available yield conflicting results, some implicating these cells in disease exacerbation, others attributing to them a protective, homeostatic function (18, 19).”
From Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis (2026) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“GSEA was performed using the Mouse MSigDB collection (68).”
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 2×
“Seurat was used to analyze data (31).”
The single-cell transcriptional landscape of mammalian organogenesis
Cao, J., Spielmann, M., Qiu, X., Huang, X., Ibrahim, D. M., Hill, A. J., Zhang, F., Mundlos, S., Christiansen, L., Steemers, F. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0969-x · Cited by 4,490 · cited 1×
“The analysis of differentiation trajectories was performed in Monocle3 using the SeuratWrapper package to convert the integrated Seurat object (69).”
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · cited 2×
“MASH occurs in approximately 20% of patients with MASLD and is characterized by steatosis, persistent inflammation, liver damage, and fibrosis (2, 3).”
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286 · cited 1×
“Despite intense clinical trials, currently there are no effective therapies for MASH (5), since the cellular and molecular mechanisms underlying MASH progression are not fully understood.”
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866 · cited 1×
“Indeed, the Treg_Foxp3 cluster had high expression of genes related to suppressive function of Tregs, such as Tig-it , Ctla4 , and Il10 , indicative of mature Tregs phenotype (45).”
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · cited 1×
“MASH occurs in approximately 20% of patients with MASLD and is characterized by steatosis, persistent inflammation, liver damage, and fibrosis (2, 3).”
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234 · cited 2×
“We found high expression of Areg , Il1rl1 , and Ikzf2 in the 1_1 cluster and these genes are feature of Tregs that function in tissue repair upon muscle injury (34).”
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174 · cited 1×
“MASH increases the risk for liver cirrhosis and hepatocellular carcinoma (HCC) and is also associated with prevalence and incidence of cardiovascular disease, chronic kidney disease, and type 2 diabetes (1, 4).”
Foxp3-dependent programme of regulatory T-cell differentiation
Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05543 · Cited by 1,135
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061 · cited 2×
“We found that dKO mice contained less hepatic Ly-6C + macrophages, which are crucial for inflammatory response and fibrosis (24, 38).”
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Joller, N., Lozano, E., Burkett, P. R., Patel, B., Xiao, S., Zhu, C., Xia, J., Tan, T. G., Sefik, E., Yajnik, V., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.012 · Cited by 955 · cited 2×
“The 1_0 cluster had high expression of Tigit , Ctla4 , Il10 , and Fgl2 , all of which were shown to be expressed on immunosuppressive Tregs (33).”
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells
Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T.-T., Gavin, M. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05563 · Cited by 835
Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784 · cited 2×
“Single-cell RNA sequencing (scRNA-Seq) studies have revealed the transcriptomic landscape of hepatic macrophages and identified the key molecules associated with MASH pathology (7–9).”
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766 · cited 1×
“MASLD causes a selective loss of hepatic CD4 + T cells, resulting in accelerated hepatocarcinogenesis (14).”
scRepertoire: An R-based toolkit for single-cell immune receptor analysis
Borcherding, N., & Bormann, N. L. (2020) · F1000Research · doi:10.12688/f1000research.22139.1 · Cited by 603 · cited 2×
“We next analyzed the TCR repertoire data obtained from scTCR sequencing data using scRepetoire (35).”
Remmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573 · cited 1×
“Innate immune response has been considered critical for MASH development, acting by triggering and propagating liver inflammation (6).”
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564 · cited 2×
“However, it has also recently emerged that T lymphocyte–mediated adaptive immunity regulates liver homeostasis in MASH (10, 11).”
Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S., Mielke, L. A., Afshar-Sterle, S., Masters, S. L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3085 · Cited by 555 · cited 1×
“Mice lacking Batf showed a reduction of tissue-infiltrating Tregs (22, 36, 56, 57), suggesting the requirement of Batf in tissue Treg development.”
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523 · cited 1×
“To investigate the function of the Nr4a family in T cells during MASH progression, we subjected mice to a cho-line-deficient, high-fat diet consisting of 60 kcal% fat and 0.1% methionine (CD) for 8 weeks (23).”
InfluentialAuto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03233-8 · Cited by 518
Quigley, M., Pereyra, F., Nilsson, B., Porichis, F., Fonseca, C., Eichbaum, Q., Julg, B., Jesneck, J. L., Brosnahan, K., Imam, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2232 · Cited by 517
Man, K., Gabriel, S. S., Liao, Y., Gloury, R., Preston, S., Henstridge, D. C., Pellegrini, M., Zehn, D., Berberich-Siebelt, F., Febbraio, M. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.021 · Cited by 506
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Wei, J., Long, L., Zheng, W., Dhungana, Y., Lim, S. A., Guy, C., Wang, Y., Wang, Y.-D., Qian, C., Xu, B., et al. (2019) · Nature · doi:10.1038/s41586-019-1821-z · Cited by 447
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution
Proto, J. D., Doran, A. C., Gusarova, G., Yurdagul, A., Sozen, E., Subramanian, M., Islam, M. N., Rymond, C. C., Du, J., Hook, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.015 · Cited by 441 · cited 1×
“Alternatively, IL-10–producing Tregs may enhance macrophage function, particularly in terms of apoptotic cell engraftment during resolution of inflammation (39).”
Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400
Wang, H., Zhang, H., Wang, Y., Brown, Z. J., Xia, Y., Huang, Z., Shen, C., Hu, Z., Beane, J., Ansa-Addo, E. A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.032 · Cited by 398 · cited 2×
“We found an increase in Foxp3 + Tregs, which exert suppression of inflammation among CD4 + T helper cell subsets in the liver of MASH mice, consistent with previous reports (16, 17).”
Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR
Zemmour, D., Zilionis, R., Kiner, E., Klein, A. M., Mathis, D., & Benoist, C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0051-0 · Cited by 384 · cited 1×
“The Treg_Helios cluster characterized with high expression of Bach2 and Satb1 and low expression of Id2 appeared to represent the resting Tregs subset (44).”
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Kadkhodaei, B., Ito, T., Joodmardi, E., Mattsson, B., Rouillard, C., Carta, M., Muramatsu, S.-I., Sumi-Ichinose, C., Nomura, T., Metzger, D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3910-09.2009 · Cited by 382 · cited 1×
“Nr4a1 fl/fl Nr4a2 fl/fl mice, which harbor floxed alleles for Nr4a1 and Nr4a2 (20, 62), were crossed with Cd4-Cre , CreER T2 (63), Foxp3 eGFlP–CreERT2 (64), Cd4Cre-ER T2 (64), or E8i.”
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374 · cited 2×
“However, it has also recently emerged that T lymphocyte–mediated adaptive immunity regulates liver homeostasis in MASH (10, 11).”
BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
Seo, H., González-Avalos, E., Zhang, W., Ramchandani, P., Yang, C., Lio, C.-W. J., Rao, A., & Hogan, P. G. (2021) · Nature Immunology · doi:10.1038/s41590-021-00964-8 · Cited by 350 · cited 1×
“Although it has been demonstrated that Batf controls CD8 + T cell expansion in tumor or chronic virus infection, the biological outcomes are likely context dependent (50–54).”
Ilan, Y., Maron, R., Tukpah, A.-M., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908771107 · Cited by 327
NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism
Pei, L., Waki, H., Vaitheesvaran, B., Wilpitz, D. C., Kurland, I. J., & Tontonoz, P. (2006) · Nature Medicine · doi:10.1038/nm1471 · Cited by 321 · cited 1×
“Interestingly, hepatic mRNA expression of Nr4a was shown to be elevated in diabetic mice, and adenoviral expression of Nr4a1 increased blood glucose levels via promoting gluconeogenesis (21).”
Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis
Sekiya, T., Kashiwagi, I., Yoshida, R., Fukaya, T., Morita, R., Kimura, A., Ichinose, H., Metzger, D., Chambon, P., & Yoshimura, A. (2013) · Nature Immunology · doi:10.1038/ni.2520 · Cited by 314 · cited 21×
“Mice lacking all Nr4a ( Nr4a1 , Nr4a2 , and Nr4a3 ) showed severe reduction of thymic and peripheral Tregs (20).”
InfluentialSelf-citationRapid generation of inducible mouse mutants
Seibler, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng012 · Cited by 305 · cited 1×
“Nr4a1 fl/fl Nr4a2 fl/fl mice, which harbor floxed alleles for Nr4a1 and Nr4a2 (20, 62), were crossed with Cd4-Cre , CreER T2 (63), Foxp3 eGFlP–CreERT2 (64), Cd4Cre-ER T2 (64), or E8i.”
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302 · cited 10×
“Metabolic dysfunction-associated steatotic liver disease (MASLD) is a liver disorder characterized by the accumulation of fat in the liver without significant alcoholic intake, and its prevalence is estimated to be around 25% (1).”
InfluentialInterleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294 · cited 1×
“Inflammatory hepatic CXCR3 + Th17 cells have been identified as the driver for MASH development (41), while lacking Il17 in mice attenuated hepatic inflammation (41–43).”
Tissue regulatory T cells: regulatory chameleons
Muñoz-Rojas, A. R., & Mathis, D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00519-w · Cited by 281 · cited 4×
“Additionally, although transcriptionally and functionally distinct Treg subpopulations from these counterparts in lymphoid organ, known as tissue Tregs, have been identified (18), it is largely unknown whether such cells could control MASH development.”
InfluentialMaekawa, Y., Minato, Y., Ishifune, C., Kurihara, T., Kitamura, A., Kojima, H., Yagita, H., Sakata-Yanagimoto, M., Saito, T., Taniuchi, I., et al. (2008) · Nature Immunology · doi:10.1038/ni.1649 · Cited by 266 · cited 1×
“Cd8Cre ( Cd8-Cre) transgenic mice (65) to generate conditional Nr4a1 - and Nr4a2 -deficient mice.”
Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization
Lu, G., Zhang, R., Geng, S., Peng, L., Jayaraman, P., Chen, C., Xu, F., Yang, J., Li, Q., Zheng, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7676 · Cited by 228
The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells
Sekiya, T., Kashiwagi, I., Inoue, N., Morita, R., Hori, S., Waldmann, H., Rudensky, A. Y., Ichinose, H., Metzger, D., Chambon, P., et al. (2011) · Nature Communications · doi:10.1038/ncomms1272 · Cited by 214 · cited 2×
“Hepatic macrophages are Tregs in the thymus and also involved in the maintenance of Tregs in the periphery (19, 20).”
Self-citationA high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury
Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R. A., Ravi, R., & Li, Z. (2007) · Hepatology · doi:10.1002/hep.21823 · Cited by 198 · cited 2×
“Tregs, which are indispensable for immune system homeostasis, acting by suppressing effector T cell response, were decreased in MASLD mice, and adaptive transfer of Tregs attenuated liver inflammation when the mice were challenged by lipopolysaccharide (15).”
Hayatsu, N., Miyao, T., Tachibana, M., Murakami, R., Kimura, A., Kato, T., Kawakami, E., Endo, T. A., Setoguchi, R., Watarai, H., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.008 · Cited by 166 · cited 2×
“Mice lacking Batf showed a reduction of tissue-infiltrating Tregs (22, 36, 56, 57), suggesting the requirement of Batf in tissue Treg development.”
Delacher, M., Simon, M., Sanderink, L., Hotz-Wagenblatt, A., Wuttke, M., Schambeck, K., Schmidleithner, L., Bittner, S., Pant, A., Ritter, U., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.007 · Cited by 164 · cited 1×
“Batf, a transcription factor belonging to the AP-1/ATF superfamily, is shown to be selectively expressed on skin and adipose tissue Tregs that have regenerative characteristics (48).”
Moreno-Fernandez, M. E., Giles, D. A., Oates, J. R., Chan, C. C., Damen, M. S. M. A., Doll, J. R., Stankiewicz, T. E., Chen, X., Chetal, K., Karns, R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.018 · Cited by 150 · cited 1×
“Inflammatory hepatic CXCR3 + Th17 cells have been identified as the driver for MASH development (41), while lacking Il17 in mice attenuated hepatic inflammation (41–43).”
A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control
Xin, G., Schauder, D. M., Lainez, B., Weinstein, J. S., Dai, Z., Chen, Y., Esplugues, E., Wen, R., Wang, D., Parish, I. A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.069 · Cited by 141
Loft, A., Alfaro, A. J., Schmidt, S. F., Pedersen, F. B., Terkelsen, M. K., Puglia, M., Chow, K. K., Feuchtinger, A., Troullinaki, M., Maida, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.005 · Cited by 129 · cited 1×
“Recent advanced transcriptome analysis delineated the landscape of intracellular crosstalk in healthy and MASH liver (9, 37).”
Savage, T. M., Fortson, K. T., de los Santos-Alexis, K., Oliveras-Alsina, A., Rouanne, M., Rae, S. S., Gamarra, J. R., Shayya, H., Kornberg, A., Cavero, R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.009 · Cited by 120 · cited 2×
“In mice, it has been shown that Tregs can positively or negatively control MASH progression, indicating dual antiinflammatory and profibrotic activities of hepatic Tregs during MASLD/MASH progression (15, 59, 60).”
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149783 · Cited by 116
Itahashi, K., Irie, T., Yuda, J., Kumagai, S., Tanegashima, T., Lin, Y.-T., Watanabe, S., Goto, Y., Suzuki, J., Aokage, K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abk0957 · Cited by 112 · cited 3×
“Mice lacking Batf showed a reduction of tissue-infiltrating Tregs (22, 36, 56, 57), suggesting the requirement of Batf in tissue Treg development.”
Tan, C., Hiwa, R., Mueller, J. L., Vykunta, V., Hibiya, K., Noviski, M., Huizar, J., Brooks, J. F., Garcia, J., Heyn, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0765-7 · Cited by 87 · cited 1×
“This Nr4a family–mediated circuit of Batf expression seems to be conserved in other cell types, as Nr4a1 and Nr4a3 restrained B cell response in the absence of costimulation through repression of Batf expression (55).”
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
Kasmani, M. Y., Zander, R., Chung, H. K., Chen, Y., Khatun, A., Damo, M., Topchyan, P., Johnson, K. E., Levashova, D., Burns, R., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220679 · Cited by 87 · cited 1×
“This innovative approach is useful to dissect the clonal expansion dynamics of T cells and track the differentiation trajectory of the clones (32, 46, 47).”
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
Du, W., Menjivar, R. E., Donahue, K. L., Kadiyala, P., Velez-Delgado, A., Brown, K. L., Watkoske, H. R., He, X., Carpenter, E. S., Angeles, C. V., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220503 · Cited by 69 · cited 1×
“On the other hand, both Arg1 and Nos2 expression were augmented in macrophages from dKO mice (Figure 3F), suggesting an immunosuppressive rather than inflammatory phenotype (26–28).”
Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion
Cai, Y., Wang, Y., Shi, C., Dai, Y., Li, F., Xu, Y., Zhang, P., Kong, F., Deng, G., Wen, Z., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211777 · Cited by 65 · cited 1×
“This innovative approach is useful to dissect the clonal expansion dynamics of T cells and track the differentiation trajectory of the clones (32, 46, 47).”
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
Lee, S., Usman, T. O., Yamauchi, J., Chhetri, G., Wang, X., Coudriet, G. M., Zhu, C., Gao, J., McConnell, R., Krantz, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154333 · Cited by 64
Bhatt, S., Qin, J., Bennett, C., Qian, S., Fung, J. J., Hamilton, T. A., & Lu, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303073 · Cited by 57 · cited 2×
“Furthermore, hepatic CD11b + cells in dKO mice displayed elevated expression of Arg1 and Nos2 , both known to be associated with tolerogenic characteristics (28).”
The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis
Dywicki, J., Buitrago‐Molina, L. E., Noyan, F., Davalos‐Misslitz, A. C., Hupa‐Breier, K. L., Lieber, M., Hapke, M., Schlue, J., Falk, C. S., Raha, S., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1807 · Cited by 57 · cited 2×
“We found an increase in Foxp3 + Tregs, which exert suppression of inflammation among CD4 + T helper cell subsets in the liver of MASH mice, consistent with previous reports (16, 17).”
Yoshimatsu, Y., Sujino, T., Miyamoto, K., Harada, Y., Tanemoto, S., Ono, K., Umeda, S., Yoshida, K., Teratani, T., Suzuki, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110773 · Cited by 53 · cited 1×
“Nr4a1 fl/fl Nr4a2 fl/fl mice, which harbor floxed alleles for Nr4a1 and Nr4a2 (20, 62), were crossed with Cd4-Cre , CreER T2 (63), Foxp3 eGFlP–CreERT2 (64), Cd4Cre-ER T2 (64), or E8i.”
Self-citationAki, D., Li, H., Zhang, W., Zheng, M., Elly, C., Lee, J. H., Zou, W., & Liu, Y. (2018) · Nature Immunology · doi:10.1038/s41590-018-0137-8 · Cited by 48 · cited 1×
“Naive CD4 + T cells were sorted and cultured as previously described (67).”
Self-citationSÖDERBERG, C., MARMUR, J., ECKES, K., GLAUMANN, H., SÄLLBERG, M., FRELIN, L., ROSENBERG, P., STÅL, P., & HULTCRANTZ, R. (2011) · APMIS · doi:10.1111/j.1600-0463.2011.02746.x · Cited by 46 · cited 1×
“Although previous studies demonstrated an increase in hepatic Tregs in humans with MASLD/MASH, similar to observations in mice (58, 59), the efficacy of Tregs in patients with MASLD/MASH has not yet been examined in a clinical setting.”
Therapeutic potential of NR4A1 in cancer: Focus on metabolism
Deng, S., Chen, B., Huo, J., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.972984 · Cited by 46 · cited 1×
“Although the therapeutic potential of Nr4a in human cancers has been recently discussed (61), there is currently insufficient evidence demonstrating the involvement of Nr4a receptors in MASH patients.”
STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets
Bhatt, D., Kang, B., Sawant, D., Zheng, L., Perez, K., Huang, Z., Sekirov, L., Wolak, D., Huang, J. Y., Liu, X., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201329 · Cited by 45
Xu, C., Fu, Y., Liu, S., Trittipo, J., Lu, X., Qi, R. A., Du, H., Yan, C., Zhang, C., Wan, J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001184 · Cited by 33 · cited 1×
“Mice lacking Batf showed a reduction of tissue-infiltrating Tregs (22, 36, 56, 57), suggesting the requirement of Batf in tissue Treg development.”
Sekiya, T., Hibino, S., Saeki, K., Kanamori, M., Takaki, S., & Yoshimura, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.008 · Cited by 25 · cited 1×
“C57BL/6-Ly5.1 were obtained from RIKEN BRC. Nr4a3-EGFP mice, which express EGFP under the control of a bacterial artificial chromosomal Nr4a3 locus, were previously described (66).”
Self-citationSekiya, T., Kagawa, S., Masaki, K., Fukunaga, K., Yoshimura, A., & Τακακι, S. (2021) · iScience · doi:10.1016/j.isci.2021.102166 · Cited by 25 · cited 1×
“Nr4a2 transduction into Tregs suppressed Batf expression, whereas dKO Tregs exhibited stronger induction upon TCR stimulation, suggesting that the Nr4a family acts as a repressor of Batf, consistent with our previous study from TGF-β –induced Tregs in vitro (49).”
Self-citation
Cited by
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“Another study demonstrated that a massive accumulation of Tregs in the livers of MASH mice ameliorated liver cell death and fi brosis, thus mitigating liver dysfunction in MASH [77].”
Role of regulatory T cells in inflammatory liver diseases
Yang, L., & Zheng, S. G. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103806 · Cited by 19
Liu, A., Huang, M., Xi, Y., Deng, X., & Xu, K. (2025) · Biomedicines · doi:10.3390/biomedicines13061422 · Cited by 17
Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis
Xie, D., Huang, Y., Yu, Y., Jin, W., Zhang, X., & Yu, F. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168062 · Cited by 13
Macrophage-tregs crosstalk: the “hub” of the immune network in MASLD
Zhao, H., Wang, W., Zhu, P., & Shi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680878 · Cited by 13
Metadata
- Authors
- Aki, D., Hayakawa, T., Srirat, T., Shichino, S., Ito, M., Saitoh, S.-I., Mise-Omata, S., & Yoshimura, A.
- Affiliations
- Wakayama Medical University (JP)
- Keio University (JP)
- Tokyo University of Science (JP)
- Kyushu University (JP)
- Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
- Corresponding author
- Aki, Daisuke
- Venue
- Journal of Clinical Investigation
- Published
- 2024-10-15
- Volume
- 134
- Issue
- 23
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11601941
- OpenAlex
- W4403424193
- Cited by
- 22
- References
- 69
- Citations by year
- 2026: 13 · 2025: 9
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- JSPS, SENSHIN Medical Research Foundation, Takeda Science Foundation, Keio Gijuku Academic Developmental Funds, AMED, Chemo-Sero-Therapeutic Research Institute, Uehara Memorial Foundation (23K06587,19K07629,21H05044,22K1944,23K06723,23H04785,21H02719,22H05064,JP23gm1110009,JP23zf0127003,22gm6210012,JP21gm6210025)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, orphan nuclear receptor, regulatory T cells, liver fibrosis, Treg proliferation, BATF, TIGIT, IL-10, hepatic macrophages, Th1/Th17 cells, hepatocyte death, T cell clonal expansion, therapeutic target
- MeSH terms
- Animals, Disease Models, Animal, Fatty Liver, Humans, Liver, Liver Cirrhosis, Male, Mice, Knockout, Cell Proliferation, T-Lymphocytes, Regulatory, Mice, Nuclear Receptor Subfamily 4, Group A, Member 1, Nuclear Receptor Subfamily 4, Group A, Member 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.